Cardinal Health Specialty Solutions has launched Cardinal Health™ Navista™ TS (Tech Solutions), an integrated suite of technology solutions to help community oncologists improve outcomes and costs associated with patient treatment as they transition to value-based care.
“Community-based oncology practices are facing unprecedented pressure as they pivot to adapt to value-based reimbursement models,” said Heidi Hunter, President of Cardinal Health Specialty Solutions. “With Navista™ TS, we are delivering the most complete set of integrated, AI-enabled solutions and actionable insights to enable oncologists to improve patient care and enhance practice performance.”
Cardinal Health has leveraged years of experience delivering practice efficiency solutions to develop an innovative suite of clinical AI and best-in-class technology in one connected solution—giving physicians and their staff the up-to-date, data-driven insights to achieve optimized care for patients and improved financial performance for their practice.
Navista™ TS is comprised of connected, point-of-service technology solutions including:
- Episode Analytics, a data-driven cost tracking tool, developed by Cardinal Health’s innovation engine, Fuse. This tool enables oncologists and administrators to accurately measure the cost of care at the start of and during the episode of care, allowing for more informed treatment decisions and clearer insights into value-based performance.
- CureMD Oncology Cloud. The integrated platform includes electronic health records (EHR), a practice management system (PMS), revenue cycle management services (RCM), a patient portal and telehealth solutions. The platform helps to simplify decision making, streamline operations and ensure a smooth transition to value-based care, saving providers time and reducing administrative burden so they can focus on patient care. CureMD and Cardinal Health will work collaboratively to provide CureMD’s oncology tech solutions.
- AI-enabled population health decision support, CORE™, by Jvion. CORE™ helps oncologists to proactively identify patients who are at, or on an accelerated path to becoming, high-risk of adverse events. The CORE surfaces the clinical and socioeconomic levers and interventions to deploy to avoid costly ER and hospital visits. Cardinal Health is the exclusive reseller of Jvion oncology products to community oncology practices.
- Clinical trials matching solution, VIPER™, powered by Deep Lens. VIPER™ uses AI to identify and match cancer patients to clinical trials, including precision medicine studies, faster and more efficiently. Cardinal Health and Deep Lens are working in collaboration to deliver VIPER™ to community oncology practices.
Through this comprehensive suite of solutions, Navista™ TS helps oncology practices understand the biggest cost and value drivers, identify treatments that offer the highest-quality care at the lowest cost, and select the right care plan at the onset of treatment. It also helps to automate manual processes and reduce administrative burdens.
Navista™ TS is backed by extensive industry research and customer-insight mining. “We started by focusing on where the market is going and by talking with customers to identify their unmet needs,” said Amy Valley, Vice President of Clinical Strategy and Technology Solutions. “One of our key findings was that practices often don’t have visibility into the cost of care for an episode until many months after a patient’s treatment plan has been determined. As a result, we focused on creating solutions that give oncologists earlier insights, so they’ll be better equipped to make decisions that will result in improved outcomes and lower costs.”
Valley said the collaborative relationship with CureMD is the newest component of Navista™ TS. “CureMD brings an ‘all in one’ solution that is very desirable to oncology practices, enabling them to access electric health records, a practice management system, revenue cycle management services, telehealth services and a patient portal – all in one place, at a competitive cost. Their technology is simple, intuitive and proven to drive enhanced practice performance,” said Valley.
Additional information about CureMD’s solutions can be found here.
Oncology practices do not need to be Cardinal Health distribution customers to purchase Navista™ TS, but existing customers and VitalSource™ GPO members will be eligible for discounts, as will early adopters and practices that provide data.
To learn more about Navista™ TS, please visit cardinalhealth.com/navista or contact Bill Winn at firstname.lastname@example.org.